Whole Exome Sequencing

Whole Exome Sequencing Data for 10 patients for treatment with the ICI Nivolumab

26 samples
DAC: EGAC00001003330
Technology: Illumina HiSeq 2500

Access Policy1 Study Files

Metadata

Request Access

Whole Exome Sequencing for patients

For each dataset that requires access control, there is a corresponding Data Access Committee (DAC) who determine access permissions. Data access requests are reviewed by the relevant DAC, not by the EGA. If you need to request access to this data set, please contact: Uri Tabori, Email: uri.tabori@sickkids.ca

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID	Study Title	Study Type
	Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency	Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID	File Type	Size	Located in